|
Volumn 24, Issue SUPPL. 1, 2011, Pages 154-155
|
Bilirubin-induced neurological damage
|
Author keywords
Early discharge neurological damage; Jaundice
|
Indexed keywords
BILIRUBIN;
MINOCYCLINE;
GLUCURONOSYLTRANSFERASE 1A1;
ARTICLE;
ATHETOSIS;
BILIRUBIN BLOOD LEVEL;
BLOOD TRANSFUSION;
BONE DEFECT;
CLINICAL FEATURE;
CRIGLER NAJJAR SYNDROME;
CYTOKINE RELEASE;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG SAFETY;
EYE MOVEMENT DISORDER;
GLUCURONIDATION;
HEARING IMPAIRMENT;
HOSPITAL DISCHARGE;
HUMAN;
HYPERBILIRUBINEMIA;
KERNICTERUS;
LEARNING DISORDER;
LIVER TRANSPLANTATION;
MEMORY DISORDER;
MOTOR DYSFUNCTION;
NEUROLOGIC DISEASE;
NEUROPROTECTION;
NEWBORN JAUNDICE;
NONHUMAN;
OUTCOME ASSESSMENT;
OXIDATIVE STRESS;
PATHOPHYSIOLOGY;
PHOTOTHERAPY;
PREVENTIVE MEDICINE;
PRIORITY JOURNAL;
SIGNAL TRANSDUCTION;
SURVIVAL RATE;
TOOTH DISEASE;
BIOACCUMULATION;
BLOOD BRAIN BARRIER;
BRAIN REGION;
DISEASE ASSOCIATION;
DISEASE DURATION;
GESTATIONAL AGE;
PRACTICE GUIDELINE;
BILIRUBIN;
HUMANS;
INFANT, NEWBORN;
JAUNDICE, NEONATAL;
NERVOUS SYSTEM DISEASES;
TRAUMA, NERVOUS SYSTEM;
|
EID: 80053285278
PISSN: 14767058
EISSN: 14764954
Source Type: Journal
DOI: 10.3109/14767058.2011.607590 Document Type: Article |
Times cited : (11)
|
References (9)
|